|
|
| |
Daunorubicin Hydrochloride for Injection USP 20 mg |
| |
Acute myeloblastic Leukemia
Neuroblastoma
Acute Lymphoblastic Leukemia
Rhabdomyosarcoma
Acute Non-Lymphatic Leukemia of adults
Remission induction in acute Lymphatic Leukemia of children and adults
|
| |
Starting Doses :
The recommended dosage in each individual may
vary from 0.5 to 3 mg/ kg.
Acute non-lymphoytic leukemia
Patients <60 yrs. of age : 45mg/m2/day.
Patients >60 yrs. of age : 30mg/m2/day.
Acute Lymphocytic Leukemia (ALL)
Paediatric : 25mg/m2
Adult : 45mg/m2
Dosage Adjustment :
Renal Impairment : Not Required.
Hepatic Impairment : Required. |
| |
Packing : |
5 Vials of 20 mg |
|
|
